Skip to main navigation Skip to search Skip to main content

Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines

  • Laurence Madera
  • , Robert E.W. Hancock

Research output: Contribution to journal › Article › peer-review

Abstract

Abstract Innate defense regulator (IDR) peptides are a class of immunomodulators which enhance and modulate host innate immune responses against microbial pathogens. While IDR-mediated protection against a range of bacterial pathogens is dependent on enhanced monocyte recruitment to the site of infection, the mechanisms through which they increase monocyte trafficking remain unclear. In this study, anti-infective peptide IDR-1002 was shown to enhance monocyte chemotaxis towards chemokines CCL3 and CCL5. This enhancement correlated with the selective upregulation of CCR5 surface expression by peptide-treated monocytes. It was found that IDR-1002 enhancement of monocyte chemotaxis was fully dependent on CCR5 function. Furthermore, IDR-1002 enhanced chemokine-induced monocyte p38 MAPK phosphorylation in a CCR5-dependent fashion. Overall, these results indicate that peptide IDR-1002 can selectively influence monocyte recruitment by host chemokines through the regulation of chemokine receptors.

Original languageEnglish
Article number34248
Pages (from-to)800-806
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume464
Issue number3
DOIs
Publication statusPublished or Issued - 7 Aug 2015
Externally publishedYes

Keywords

  • Chemokine receptors
  • Chemokines
  • Immunomodulation
  • Innate defense regulators
  • Monocytes

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this